NeuroMetrix Inc
NASDAQ:NURO
EV/S
Enterprise Value to Sales
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
Market Cap | EV/S | ||||
---|---|---|---|---|---|
US |
NeuroMetrix Inc
NASDAQ:NURO
|
8.8m USD | -1.6 | ||
US |
Abbott Laboratories
NYSE:ABT
|
180.9B USD | 4.6 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
136.3B USD | 17.9 | ||
US |
Stryker Corp
NYSE:SYK
|
123.5B USD | 6.3 | ||
IE |
Medtronic PLC
NYSE:MDT
|
112.1B USD | 4 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
108B USD | 7.8 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
67.9B USD | 4.1 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
59.2B EUR | 3.2 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
375.2B CNY | 9.9 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
52B USD | 8.3 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
49.7B USD | 13 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.